Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage
Authors
Qiheng He (ORCID: https://orcid.org/0000-0001-6715-298X)
Yong Cao (ORCID: https://orcid.org/0000-0002-8289-1120)
Ran Huo (ORCID: https://orcid.org/0000-0003-4708-3133)
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Funders
Beijing Municipal Health Commission
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage
Qiheng He, Yong Cao, Ran Huo, Ni Yang et al.
Journal
Stroke and Vascular Neurology
Topics
Intracerebral and Subarachnoid Hemorrhage Research
article
Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage
Qiheng He, Yong Cao, Ran Huo, Ni Yang, Yuming Jiao, Pengqi Wang, Shaozhi Zhao, Mingze Wang, Xiao Bai, Zhiyou Wu, Jinyi Tang, Duolao Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
Stroke and Vascular Neurology
Institutions
Capital Medical University (CN), Liverpool School of Tropical Medicine (GB), Beijing Tian Tan Hospital (CN), National Clinical Research Center for Digestive Diseases (CN)
Funders
Beijing Municipal Health Commission
OpenAlex Percentile
Openalex Percentile: Top 63%
Topics
Intracerebral and Subarachnoid Hemorrhage Research